Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessing Cardiac Metabolism
Heinrich Taegtmeyer, Martin E. Young, Gary D. Lopaschuk, et al.
Circulation Research (2016) Vol. 118, Iss. 10, pp. 1659-1701
Open Access | Times Cited: 250

Showing 1-25 of 250 citing articles:

Obesity Phenotypes, Diabetes, and Cardiovascular Diseases
Marie‐Ève Piché, André Tchernof, Jean–Pierre Després
Circulation Research (2020) Vol. 126, Iss. 11, pp. 1477-1500
Open Access | Times Cited: 1302
Cardiovascular Metabolomics
Robert W. McGarrah, Scott B. Crown, Guo‐Fang Zhang, et al.
Circulation Research (2018) Vol. 122, Iss. 9, pp. 1238-1258
Open Access | Times Cited: 352
The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease
John R. Ussher, Sammy Elmariah, Robert E. Gerszten, et al.
Journal of the American College of Cardiology (2016) Vol. 68, Iss. 25, pp. 2850-2870
Closed Access | Times Cited: 311
Metabolic Coordination of Physiological and Pathological Cardiac Remodeling
Andrew Gibb, Bradford G. Hill
Circulation Research (2018) Vol. 123, Iss. 1, pp. 107-128
Open Access | Times Cited: 304
The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense
Julie L. Horton, Michael T. Davidson, Clara Kurishima, et al.
JCI Insight (2019) Vol. 4, Iss. 4
Open Access | Times Cited: 303
Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision
Ashif Iqubal, Mohammad Kashif Iqubal, Sumit Sharma, et al.
Life Sciences (2018) Vol. 218, pp. 112-131
Closed Access | Times Cited: 257
Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy
Sara Ranjbarvaziri, Kristina B. Kooiker, Mathew Ellenberger, et al.
Circulation (2021) Vol. 144, Iss. 21, pp. 1714-1731
Open Access | Times Cited: 171
Metabolic inflammation in heart failure with preserved ejection fraction
Gabriele G. Schiattarella, Daniele Rodolico, Joseph A. Hill
Cardiovascular Research (2020) Vol. 117, Iss. 2, pp. 423-434
Open Access | Times Cited: 170
Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies
Qiao Jin, Ronald C.W.
Cells (2021) Vol. 10, Iss. 11, pp. 2832-2832
Open Access | Times Cited: 160
Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure
Senthil Selvaraj, Daniel P. Kelly, Kenneth B. Margulies
Circulation (2020) Vol. 141, Iss. 22, pp. 1800-1812
Open Access | Times Cited: 158
Cardiac metabolism as a driver and therapeutic target of myocardial infarction
Coert J. Zuurbier, Luc Bertrand, Christoph R. Beauloye, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 11, pp. 5937-5954
Open Access | Times Cited: 156
Short-chain fatty acid, acylation and cardiovascular diseases
Xiaofeng Chen, Xiangqi Chen, Xiaoqiang Tang
Clinical Science (2020) Vol. 134, Iss. 6, pp. 657-676
Closed Access | Times Cited: 149
Progress in multicellular human cardiac organoids for clinical applications
Hyeonyu Kim, Roger D. Kamm, Gordana Vunjak‐Novakovic, et al.
Cell stem cell (2022) Vol. 29, Iss. 4, pp. 503-514
Open Access | Times Cited: 81
MOXI Is a Mitochondrial Micropeptide That Enhances Fatty Acid β-Oxidation
Catherine A. Makarewich, Kedryn K. Baskin, Amir Z Munir, et al.
Cell Reports (2018) Vol. 23, Iss. 13, pp. 3701-3709
Open Access | Times Cited: 149
The diabetic heart utilizes ketone bodies as an energy source
Yuji Mizuno, Eisaku Harada, Hitoshi Nakagawa, et al.
Metabolism (2017) Vol. 77, pp. 65-72
Open Access | Times Cited: 138
Comprehensive Metabolomic Profiling and Incident Cardiovascular Disease: A Systematic Review
Miguel Ruiz‐Canela, Adela Hruby, Clary B. Clish, et al.
Journal of the American Heart Association (2017) Vol. 6, Iss. 10
Open Access | Times Cited: 134
Follistatin-like 1 in development and human diseases
Andrea Mattiotti, Stuti Prakash, Phil Barnett, et al.
Cellular and Molecular Life Sciences (2018) Vol. 75, Iss. 13, pp. 2339-2354
Open Access | Times Cited: 134
Metabolic support for the heart: complementary therapy for heart failure?
Ward Heggermont, Anna‐Pia Papageorgiou, Stéphane Heymans, et al.
European Journal of Heart Failure (2016) Vol. 18, Iss. 12, pp. 1420-1429
Open Access | Times Cited: 104
KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy
Ioannis D. Kyriazis, Matthew Hoffman, Lea Gaignebet, et al.
Circulation Research (2020) Vol. 128, Iss. 3, pp. 335-357
Open Access | Times Cited: 103
Cardiac ketone body metabolism
Azrul Abdul Kadir, Kieran Clarke, Rhys Evans
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 6, pp. 165739-165739
Closed Access | Times Cited: 91
Molecular Atlas of Postnatal Mouse Heart Development
Virpi Talman, Jaakko Teppo, Päivi Pöhö, et al.
Journal of the American Heart Association (2018) Vol. 7, Iss. 20
Open Access | Times Cited: 89
Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure
Arata Fukushima, Gary D. Lopaschuk
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2016) Vol. 1862, Iss. 12, pp. 2211-2220
Open Access | Times Cited: 86
Metabolic Mechanisms of Exercise-Induced Cardiac Remodeling
Kyle Fulghum, Bradford G. Hill
Frontiers in Cardiovascular Medicine (2018) Vol. 5
Open Access | Times Cited: 86
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date
Lavanya Athithan, Gaurav S. Gulsin, Gerry P McCann, et al.
World Journal of Diabetes (2019) Vol. 10, Iss. 10, pp. 490-510
Open Access | Times Cited: 78
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1834-1834
Open Access | Times Cited: 73
Page 1 - Next Page

Scroll to top